| Issue Date | Title | Author(s) |
1 | 2013 | Changes in molecular biology of chronic myeloid leukemia in tyrosine kinase inhibitor era | Cömert, Melda; Baran, Yusuf ; Saydam, Güray |
2 | Jun-2013 | Mechanisms responsible for nilotinib resistance in human chronic myeloid leukemia cells and reversal of resistance | Camgöz, Aylin; Gençer, Emel Başak; Ural, Ali Uğur; Baran, Yusuf |
3 | Apr-2013 | miR-17 in imatinib resistance and response to tyrosine kinase inhibitors in chronic myeloid leukemia cells | Fıratlıgil, Burcu ; Biray Avcı, Çığır; Baran, Yusuf |
4 | Jul-2013 | The roles of epigenetic modifications of proapoptotic BID and BIM genes in imatinibresistant chronic myeloid leukemia cells | Bozkurt, Süreyya; Özkan, Tülin; Özmen, Füsun; Baran, Yusuf ; Sunguroglu, Asuman; Kansu, Emin |
5 | Apr-2013 | The roles of macromolecules in imatinib resistance of chronic myeloid leukemia cells by Fourier transform infrared spectroscopy | Baran, Yusuf ; Ceylan, Çağatay ; Camgöz, Aylin |
6 | Jul-2013 | STAT pathway in the regulation of zoledronic acid-induced apoptosis in chronic myeloid leukemia cells | Kiper, Hatice Demet; Tezcanlı Kaymaz, Burçin; Adan Gökbulut, Aysun ; Selvi, Nur; Biray Avcı, Çığır; Kosova, Buket; İskender, Güniz; Kartal Yandım, Melis; Gündüz, Cumhur; Şahin, Fahri; Baran, Yusuf ; Saydam, Güray |